Literature DB >> 21655150

Cord stem-cell transplantation in Ontario: do we need a public bank?

A Gassas1.   

Abstract

It has been 21 years since the first successful use of umbilical cord blood as a source of donor cells for hematopoietic stem cell transplantation (HSCT). Over those years, cord blood transplantation (CBT) has shown marked success as an effective modality in the treatment of children and adults with hematologic malignancies, marrow failure, immunodeficiency, hemoglobinopathy, and inherited metabolic diseases. Furthermore, transplantation without full human leukocyte antigen (HLA) matching is possible and, despite a lower incidence of graft-versus-host disease, graft-versus-leukemia effect is preserved. More than 20,000 cbts have been performed worldwide. Ontario is the most populated province in Canada, and its cbt numbers have increased dramatically in recent years, but most of the umbilical cord blood units are purchased from unrelated international registries. There is no public cord bank in Ontario, but there is a private cord banking option, and notably, Ontario has the largest number of live births in Canada [approximately 40% of all Canadian live births per year occur in Ontario (Statistics Canada, 2007)]. In this brief review, the pros and cons of private and public cord banking and the feasibility of starting an Ontario public cord bank are discussed.

Entities:  

Keywords:  Cord stem-cell transplantation; Ontario; children; private cord banking; public cord banking

Year:  2011        PMID: 21655150      PMCID: PMC3108872          DOI: 10.3747/co.v18i3.742

Source DB:  PubMed          Journal:  Curr Oncol        ISSN: 1198-0052            Impact factor:   3.677


  15 in total

Review 1.  Adult umbilical cord blood transplantation: a comprehensive review.

Authors:  H Schoemans; K Theunissen; J Maertens; M Boogaerts; C Verfaillie; J Wagner
Journal:  Bone Marrow Transplant       Date:  2006-06-05       Impact factor: 5.483

Review 2.  Umbilical cord blood: a unique source of pluripotent stem cells for regenerative medicine.

Authors:  David T Harris; Ian Rogers
Journal:  Curr Stem Cell Res Ther       Date:  2007-12       Impact factor: 3.828

3.  Placental blood transplantation and autologous banking--caveat emptor.

Authors:  F L Johnson
Journal:  J Pediatr Hematol Oncol       Date:  1997 May-Jun       Impact factor: 1.289

4.  Transplants of umbilical-cord blood or bone marrow from unrelated donors in adults with acute leukemia.

Authors:  Vanderson Rocha; Myriam Labopin; Guillermo Sanz; William Arcese; Rainer Schwerdtfeger; Alberto Bosi; Niels Jacobsen; Tapani Ruutu; Marcos de Lima; Jürgen Finke; Francesco Frassoni; Eliane Gluckman
Journal:  N Engl J Med       Date:  2004-11-25       Impact factor: 91.245

5.  Human umbilical cord blood as a potential source of transplantable hematopoietic stem/progenitor cells.

Authors:  H E Broxmeyer; G W Douglas; G Hangoc; S Cooper; J Bard; D English; M Arny; L Thomas; E A Boyse
Journal:  Proc Natl Acad Sci U S A       Date:  1989-05       Impact factor: 11.205

6.  Survival after transplantation of unrelated donor umbilical cord blood is comparable to that of human leukocyte antigen-matched unrelated donor bone marrow: results of a matched-pair analysis.

Authors:  J N Barker; S M Davies; T DeFor; N K Ramsay; D J Weisdorf; J E Wagner
Journal:  Blood       Date:  2001-05-15       Impact factor: 22.113

7.  [The expansion and biological characteristics of human mesenchymal stem cells].

Authors:  Dun-hua Zhou; Shao-lfang Huang; Yan-Feng Wu; Jing Wei; Ge-yu Chen; Yang Li; Rong Bao
Journal:  Zhonghua Er Ke Za Zhi       Date:  2003-08

Review 8.  History of cord blood transplantation.

Authors:  E Gluckman
Journal:  Bone Marrow Transplant       Date:  2009-10-05       Impact factor: 5.483

9.  Autologous nonmyeloablative hematopoietic stem cell transplantation in newly diagnosed type 1 diabetes mellitus.

Authors:  Júlio C Voltarelli; Carlos E B Couri; Ana B P L Stracieri; Maria C Oliveira; Daniela A Moraes; Fabiano Pieroni; Marina Coutinho; Kelen C R Malmegrim; Maria C Foss-Freitas; Belinda P Simões; Milton C Foss; Elizabeth Squiers; Richard K Burt
Journal:  JAMA       Date:  2007-04-11       Impact factor: 56.272

10.  The use of umbilical cord blood in mismatched related and unrelated hemopoietic stem cell transplantation.

Authors:  J Kurtzberg; M Graham; J Casey; J Olson; C E Stevens; P Rubinstein
Journal:  Blood Cells       Date:  1994
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.